Active Ingredient(s):Apremilast FDA Approved: * March 21, 2014 Pharm Company: *CELGENE Category:Arthritis
Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. It may also be useful for other immune system-related inflammatory diseases. The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4) and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells. It is taken by mouth.
1 Medical uses
* May have multiple approval dates, manufacturers, or labelers. 5 Discussions